Moneycontrol
you are here: HomeNewsBusiness
Last Updated : May 14, 2018 10:35 AM IST | Source: PTI

USFDA completes inspection of Lupin's Nagpur plant

In a BSE filing, Lupin "announced successful completion of an inspection carried out by the United States Food and Drug Administration (USFDA) at its Nagpur facility. The inspection concluded without any observations".

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Pharma major Lupin today said the US health regulator has completed inspection of its Nagpur facility without making any observations.

In a BSE filing, Lupin "announced successful completion of an inspection carried out by the United States Food and Drug Administration (USFDA) at its Nagpur facility. The inspection concluded without any observations".

Lupin said its Nagpur facility manufactures oral solid products.

Shares of Lupin were trading 2.09 percent higher at Rs 767.50 on BSE.
First Published on May 14, 2018 10:31 am
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant